Navigation Links
General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results
Date:11/11/2008

PITTSBURGH, Nov. 11 /PRNewswire/ -- General Nutrition Centers, Inc. ("GNC" the "Company" or "we"), the largest global specialty retailer of nutritional supplements, today reported its financial results for the third quarter ended September 30, 2008.

The Company is an indirect wholly owned subsidiary of GNC Parent LLC, which was acquired by affiliates of Ares Management LLC ("Ares") and Ontario Teachers' Pension Plan Board ("Teachers") through a merger (the "Merger") on March 16, 2007. As a result, the financial results presented in this press release represent the aggregate of the financial results of the Company from January 1, 2007 through March 15, 2007, predecessor, and the results from March 16, 2007 to September 30, 2007 and for the nine months ended September 30, 2008, successor.

For the third quarter of 2008, the Company reported revenues of $414.2 million, a 4.8% increase over the same quarter in 2007. This increase was the result of increased revenues in each of the Company's business segments: Retail by 3.2%; Franchise by 2.7%; and Manufacturing/Wholesale by 19.4%. Same store sales improved 1.5% in domestic company-owned stores (including internet sales), and 5.5% in Canadian stores.

For the third quarter of 2008, the Company reported earnings before interest, income taxes, depreciation and amortization (EBITDA) of $54.3 million compared to $44.0 million for the same quarter in 2007. Included in the third quarter of 2007 was $7.1 million of non-cash purchase accounting adjustments resulting from the Merger. Included as part of compensation expense for the third quarters of 2008 and 2007 was $0.7 million of non-cash stock-based compensation expense. Excluding these non-cash and purchase accounting related expenses, Adjusted EBITDA was $55.0 million for the third quarter of 2008, a 6.2% increase over Adjusted EBITDA of $51.8 million for the third quarter of 2007, on top of a 18.5% third quarter 2007 Adjusted EBITDA growth.

Revenue for the first nine months of 2008 was $1,265.0 million, a 7.5% increase over the same period in 2007. For the first nine months of 2008, the Company reported EBITDA of $166.4 million compared to $79.9 million for the same period in 2007. Compensation expense for the first nine months of 2008 and 2007 included $2.2 million and $1.7 million, respectively, of non-cash stock-based compensation expense. EBITDA for the first nine months of 2007 reflected $65.3 million of transaction and purchase accounting costs related to the Merger. Excluding non-cash compensation expense and Merger-related transaction costs, Adjusted EBITDA was $168.6 million for the first nine months of 2008 compared to $146.9 million in the same period of 2007, a 14.8% increase. This is in addition to a 14.9% Adjusted EBITDA growth in the first nine months of 2007.

The transaction costs and Merger-related expenses incurred in the first nine months of 2007 included: $34.6 million of transaction fees and expenses; $15.3 million of compensation expenses (including $3.8 million of non-cash stock-based compensation resulting from the cancellation of all outstanding stock options); and $15.4 million of non-cash purchase accounting adjustments recorded as part of cost of sales.

GNC, headquartered in Pittsburgh, Pa., is the largest global specialty retailer of nutritional products including vitamin, mineral, herbal and other specialty supplements and sports nutrition, diet and energy products. GNC has more than 5,000 retail locations throughout the United States (including more than 950 franchise and 1,650 Rite Aid store-within-a-store locations) and franchise operations in 44 international markets. The company - which is dedicated to helping consumers Live Well - also offers products and product information online at http://www.gnc.com.

GNC has scheduled a conference call and webcast to report its third quarter financial results on Tuesday, November 11, 2008 at 11:00 am ET. To listen to this call dial 1-800-471-6718 inside the U.S. and dial 1-630-691- 2735 outside the U.S. The conference identification number for all callers is 23123532. A webcast of the call will also be available through the "About GNC" link on http://www.gnc.com.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business that is not historical information. Forward-looking statements can be identified by the use of terminology such as "subject to," "believes," "anticipates," "plans," "expects," "intends," "estimates," "projects," "may," "will," "should," "can," the negatives thereof, variations thereon and similar expressions, or by discussions of strategy. GNC believes there is a reasonable basis for our expectations and beliefs, but they are inherently uncertain, we may not realize our expectations and our beliefs may not prove correct. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Actual results could differ materially from those described or implied by such forward-looking statements. Factors that may materially affect such forward- looking statements include, among others:

-- general economic conditions, including weakening of the economy and

consumer purchases;

-- significant competition in our industry;

-- unfavorable publicity or consumer perception of our products;

-- the incurrence of material products liability and product recall costs;

-- costs of compliance and our failure to comply with governmental

regulations;

-- the failure of our franchisees to conduct their operations profitably

and limitations on our ability to terminate or replace under-performing

franchisees;

-- economic, political and other risks associated with our international

operations;

-- our failure to keep pace with the demands of our customers for new

products and services;

-- the lack of long-term experience with human consumption of some of our

products with innovative ingredients;

-- disruptions in our manufacturing system or losses of manufacturing

certifications;

-- increases in the frequency and severity of insurance claims,

particularly for claims for which we are self-insured;

-- loss or retirement of key members of management;

-- increases in the cost of borrowings and unavailability of additional

debt or equity capital;

-- the impact of our substantial indebtedness on our operating income and

our ability to grow;

-- the failure to adequately protect or enforce our intellectual property

rights against competitors;

-- changes in applicable laws relating to our franchise operations; and

-- our inability to expand our franchise operations to attract new

franchisees.

Results of Operations

(Dollars in millions and percentages expressed as a percentage of total

net revenues)

Successor

Three Months Ended September 30,

2008 2007

Revenues:

Retail $298.8 72.1% $289.4 73.2%

Franchise 67.5 16.3% 65.8 16.7%

Manufacturing / Wholesale 47.9 11.6% 40.1 10.1%

Total net revenues 414.2 100.0% 395.3 100.0%

Operating expenses:

Cost of sales, including

warehousing, distribution and

occupancy costs 270.0 65.2% 264.6 67.0%

Compensation and related benefits 63.3 15.3% 61.8 15.6%

Advertising and promotion 13.6 3.3% 13.4 3.4%

Other selling, general and

administrative expenses 21.1 5.1% 18.1 4.6%

Amortization expense 2.6 0.6% 3.3 0.8%

Foreign currency loss (gain) 0.1 0.0% (0.2) -0.1%

Transaction related costs - 0.0% - 0.0%

Total operating expenses 370.7 89.5% 361.0 91.3%

Operating income:

Retail 32.6 7.9% 32.1 8.1%

Franchise 22.6 5.4% 20.3 5.1%

Manufacturing / Wholesale 18.9 4.6% 10.6 2.7%

Unallocated corporate and other

costs:

Warehousing and distribution

costs (13.5) -3.3% (12.9) -3.2%

Corporate costs (17.1) -4.1% (15.7) -4.0%

Merger related costs - 0.0% - 0.0%

Subtotal unallocated corporate and

other costs, net (30.6) -7.4% (28.6) -7.2%

Total operating income 43.5 10.5% 34.4 8.7%

Interest expense, net 19.7 23.8

Income (loss) before income taxes 23.8 10.6

Income tax expense (benefit) 7.5 4.5

Net income (loss) $16.3 $6.1

Successor Combined

Nine Months Ended Nine Months Ended

September 30, September 30,

2008 2007

Revenues:

Retail $934.6 73.9% $890.0 75.6%

Franchise 197.5 15.6% 184.5 15.7%

Manufacturing / Wholesale 132.9 10.5% 102.2 8.7%

Total net revenues 1,265.0 100.0% 1,176.7 100.0%

Operating expenses:

Cost of sales, including

warehousing, distribution and

occupancy costs 823.1 65.1% 780.0 66.3%

Compensation and related benefits 187.8 14.8% 196.6 16.7%

Advertising and promotion 45.4 3.6% 48.4 4.1%

Other selling, general and

administrative expenses 65.2 5.1% 58.2 4.9%

Amortization expense 8.3 0.7% 6.9 0.6%

Foreign currency loss (gain) 0.2 0.0% (0.5) 0.0%

Transaction related costs - 0.0% 34.6 2.9%

Total operating expenses 1,130.0 89.3% 1,124.2 95.5%

Operating income:

Retail 111.6 8.8% 99.2 8.5%

Franchise 61.1 4.9% 53.3 4.5%

Manufacturing / Wholesale 52.0 4.1% 34.0 2.9%

Unallocated corporate and other

costs:

Warehousing and distribution

costs (41.1) -3.3% (38.1) -3.3%

Corporate costs (48.6) -3.8% (61.2) -5.2%

Merger related costs - 0.0% (34.6) -2.9%

Subtotal unallocated corporate and

other costs, net (89.7) -7.1% (133.9) -11.4%

Total operating income 135.0 10.7% 52.6 4.5%

Interest expense, net 62.2 94.7

Income (loss) before income taxes 72.8 (42.1)

Income tax expense (benefit) 26.1 (2.5)

Net income (loss) $46.7 $(39.6)

Note: The numbers in the above table have been rounded to millions. All calculations related to the Results of Operations for the year-over-year comparisons were derived from the table above and could occasionally differ immaterially if you were to use the unrounded data for these calculations.

We define EBITDA as net income (loss) before interest expense (net), income tax expense, depreciation, and amortization. Management uses EBITDA as a tool to measure operating performance of the business. We use EBITDA as one criterion for evaluating our performance relative to our competitors and also as a measurement for the calculation of management incentive compensation. Although we primarily view EBITDA as an operating performance measure, we also consider it to be a useful analytical tool for measuring our liquidity, our leverage capacity, and our ability to service our debt and generate cash for other purposes.

We also use EBITDA as defined in our 2007 Senior Credit Facility, and the indentures governing our Senior Toggle Notes and 10.75% Senior Subordinated Notes to determine compliance with the terms of the facility and the Notes. The reconciliation of EBITDA as presented below is different than that used for purposes of the covenants under the indentures governing the Senior Toggle Notes and 10.75% Senior Subordinated Notes, and it is also different than that used in our 2007 Senior Credit Facility. Historically, we have highlighted our use of EBITDA as a liquidity measure and for related purposes because of our focus on the holders of our debt. At the same time, however, management has also internally used EBITDA as a performance measure. EBITDA is not a measurement of our financial performance under GAAP and should not be considered as an alternative to net income, operating income, or any other performance measures derived in accordance with GAAP, or as an alternative to GAAP cash flow from operating activities, as a measure of our profitability or liquidity.

Adjusted EBITDA is presented as additional information, as management also uses Adjusted EBITDA to evaluate the operating performance of the business and as a measurement for the calculation of management incentive compensation. Management believes that EBITDA and Adjusted EBITDA are commonly used by securities analysts, lenders and others; however, EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures reported by other companies, limiting their usefulness as comparative measures.

Some of the limitations of EBITDA and Adjusted EBITDA are as follows:

-- EBITDA and Adjusted EBITDA do not reflect cash expenditures, future requirements for capital expenditures or contractual commitments;

-- EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for working capital needs;

-- EBITDA and Adjusted EBITDA do not reflect interest expense or the cash requirement necessary to service interest or principal payments on our debt; although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements; and

-- EBITDA and Adjusted EBITDA reflect the impact of earnings on income resulting from matters we consider not to be indicative of our ongoing operations, certain of which income we eliminated in our computation of EBITDA and Adjusted EBITDA.

Because of these limitations, EBITDA and Adjusted EBITDA should not be considered as measures of discretionary cash available to us to invest in our business. We compensate for these limitations by relying primarily on our GAAP results and using EBITDA only for supplemental purposes.

For the three months ended September 30, 2008 and September 30, 2007, the nine months ended September 30, 2008 and the combined predecessor and successor periods ended September 30, 2007, the following table presents EBITDA reconciled to our net income for such periods and Adjusted EBITDA reconciled to EBITDA for such periods.

NET INCOME (LOSS) RECONCILIATION TO EBITDA AND ADJUSTED EBITDA

(in millions)

(unaudited) Successor Successor Combined

Three Months Ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Net income (loss) $16.3 $6.1 $46.7 $(39.6)

Interest expense, net 19.7 23.8 62.2 94.7

Income tax expense (benefit) 7.5 4.5 26.1 (2.5)

Depreciation and amortization 10.8 9.6 31.4 27.3

EBITDA $54.3 $44.0 $166.4 $79.9

Transaction costs - - - 34.6

Compensation expense related to

transaction - - - 15.3

Non-cash stock based compensation

expense 0.7 0.7 2.2 1.7

Purchase accounting adjustments - 7.1 - 15.4

Adjusted EBITDA $55.0 $51.8 $168.6 $146.9

For the three months ended September 30, 2008 and September 30, 2007, the nine months ended September 30, 2008 and the combined predecessor and successor periods ended September 30, 2007, the following table presents EBITDA reconciled to our cash from operations for such periods and Adjusted EBITDA reconciled to EBITDA for such periods.

CASH FROM OPERATIONS RECONCILIATION TO EBITDA AND ADJUSTED EBITDA

(in millions)

(unaudited) Successor Successor Combined

Three Months Ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Net cash provided by (used in)

operating activities $13.4 $4.0 $65.4 $(1.6)

Cash paid for interest (excluding

deferred financing fees) 26.5 33.6 69.4 74.9

Cash paid (received) for taxes 3.1 (5.5) 9.5 (3.7)

Increase (decrease) in accounts

receivable 4.0 4.6 2.7 12.2

Increase (decrease) in inventory 24.9 - 33.4 (12.9)

Decrease (increase) in accounts

payable (19.8) 1.8 (21.8) 0.3

Increase (decrease) in other assets (0.4) - (1.9) (2.7)

Decrease (increase) in other

liabilities 2.6 5.5 9.7 13.4

EBITDA $54.3 $44.0 $166.4 $79.9

Transaction costs - - - 34.6

Compensation expense related to

transaction - - - 15.3

Non-cash stock based compensation

expense 0.7 0.7 2.2 1.7

Purchase accounting adjustments - 7.1 - 15.4

Adjusted EBITDA $55.0 $51.8 $168.6 $146.9


'/>"/>
SOURCE General Nutrition Centers, Inc.
Copyright©2008 PR Newswire.
All rights reserved


Related medicine news :

1. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
2. General anesthesia for hernia surgery in children and risk of later developmental problems
3. SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER
4. General Dynamics Honored with the 2008 Outstanding Contractor Award by the Administration for Children and Families
5. General Mills, Inc. Launches One-Of-A-Kind Grassroots Health and Nutrition Initiative Designed to Help Hispanic Families Eat Better
6. Cuts at General Motors Bring Benefit Trends to the Forefront
7. Air Methods Awarded $15 Million Contract From General Dynamics Land Systems
8. Auditor General Jack Wagner Praises Army for Saving Kelly Support Facility Commissary
9. General Anesthesia Tied to Developmental Woes in Kids
10. Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms
11. ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... United Methodist Communications collaborated ... Prevention,” an animated video designed to prevent the next widespread Ebola ... video are being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and ...
(Date:2/9/2016)... FL (PRWEB) , ... February 09, 2016 , ... Shark Finds and Kevin ... new DRTV campaign with GRIP-DRY. , GRIP-DRY is a newly patented product that has solved ... who play in the wet and early morning dew or right after a rain shower, ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... launched its newly redesigned website, federallabs.org . The site houses a wealth ... license available federal technologies through the process called technology transfer (T2). As a ...
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance Agency, serving ... a new charity campaign. As part of their ongoing community involvement program, funds ... belief that children deserve a voice, and in the spirit of neighbors helping ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... BantamPro L top-load case packer for pouches, bags, and flow wrapped products at ... help co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... ORLANDO, Florida , February 9, 2016 /PRNewswire/ ... QIA) today announced a collaboration with 10x Genomics ... sequencing (NGS), single-cell biology and bioinformatics. --> ... announced a collaboration with 10x Genomics to develop ... single-cell biology and bioinformatics. --> QIAGEN ...
(Date:2/9/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a ... and heart failure, today announced that it intends to offer ... in an underwritten public offering.  The offering is subject to ... as to whether or when the offering may be completed, ... offering.   --> --> ...
Breaking Medicine Technology: